Search

everythinglearnresearchcommunity

for

Search:↓

Steroidogenesis inhibitors change but don't stop androgen production in prostate cancer.

Tofacitinib is a promising treatment for children with rheumatic diseases.

Combining a GnRH agonist with a low-dose oral contraceptive is more effective and safer for treating hirsutism than using either alone.

Cepharanthine can potentially treat gastric cancer by stopping tumor growth.

LX-38 is a safer drug option for hair loss and prostate issues without hormonal side effects.

Some dibenzo compounds might help treat cancer with fewer side effects.

Strontium ranelate helps cartilage growth by blocking a specific cell pathway.

Silencing SFRP1 alone promotes hair growth, but adding DKK1 does not help.

Plant-based compounds may offer safer prostate cancer treatment with fewer side effects.

A new compound, 3a, effectively fights prostate cancer better than finasteride.

The framework helps predict adverse effects of blood thinners, improving drug selection for atrial fibrillation.

Androgen receptors help prostate cancer cells grow and resist drugs.

Certain histamine receptors (H2R, H3R, H4R) have unique roles in treating skin diseases, with H2R helping with chronic urticaria and other conditions, H3R providing pain relief and allergy benefits, and H4R reducing inflammation and itchiness.

ROR-alpha may increase the growth of certain breast cancer cells by boosting aromatase, which could affect breast cancer prognosis.

CRET therapy affects inflammation in skin cells by changing cytokine levels and activating certain proteins.

Strontium ranelate helps cartilage growth by blocking a specific cell pathway.

Researchers developed a model to predict how well certain compounds can block an enzyme related to hair loss and prostate issues, suggesting a 50 mg dose of finasteride might be effective based on lab and body data.

New compounds were made and tested, with compound 6 showing potential for treating prostate-related diseases.

RORA affects hair follicle stem cells' structure and movement, potentially helping treat hair loss.

Ritlecitinib is the first FDA-approved pill for treating significant hair loss in alopecia areata patients aged 12 and up.

"Flosin – Prostamol Uno" effectively manages BPH symptoms with fewer side effects.

Finasteride irreversibly affects human steroid 5α-reductase 2, providing insight into its catalytic mechanism and disease-related mutations.

Higher levels of certain proteins may increase or decrease rosacea risk.

FOXC1 boosts SFRP1 in hair loss, suggesting new treatments.

BMS-470539 reduces skin fibrosis and inflammation.

Some prostate cancers have gene changes that may affect treatment with certain drugs.

CRAC channels are crucial for the development and function of specialized immune cells, preventing severe inflammation and autoimmune diseases.

New compounds may help treat heart disease by activating specific potassium channels.

PRF is promising for dental and aesthetic uses but needs more research.